Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
Jun TomioHayato YamanaHiroki MatsuiHiroyuki YamashitaTakashi YoshiyamaHideo YasunagaPublished in: International journal of rheumatic diseases (2017)
Tuberculosis screening was often not performed prior to anti-TNF therapy despite the guidelines' recommendations; thus, patients could be put at unnecessary risk of reactivation of tuberculosis.
Keyphrases
- health insurance
- mycobacterium tuberculosis
- end stage renal disease
- pulmonary tuberculosis
- rheumatoid arthritis
- hiv aids
- affordable care act
- ejection fraction
- adverse drug
- chronic kidney disease
- newly diagnosed
- clinical practice
- prognostic factors
- oxidative stress
- patient reported outcomes
- stem cells
- hepatitis c virus
- human immunodeficiency virus
- antiretroviral therapy
- drug induced